Research & Development

在线精品视频/这里总有您喜欢的任你干在线精品视频/这里总有您喜欢的日日啪易到宣布22日司机提现再延迟:乘客可付现金 公司没倒


  如果是壞事,陛下有足夠的力量跟時間來糾正,如果是好事,那就順其自然。   霍光道︰“你沒有問題了,我有問題,殺馬合的時候少一個高手坐鎮。”在线精品视频/这里总有您喜欢的任你干 第六十二章 泥沼一樣的雲瑯在线精品视频/这里总有您喜欢的   司馬遷自然知道老友在想些什麼,指著遠去的夏侯靜道︰“你要是願意在這里下十年苦功,你也會有大成就的。”   劉徹點點頭,瞅著站在泥水里的隋越道︰“是否有人欺辱與你?”日日啪   汗血馬在敦煌停留了很久,在武威也停留了很久,在這段時間里,汗血馬已經導致十六匹母馬受孕。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo